1. AB1260 Baseline characteristics and patient satisfaction data from coach@home: the german support program for patients with rheumatic diseases treated with certolizumab pegol. (12th June 2018) Authors: Böhme, N.; Holst, A.-D.; Dybowski, F.; Volberg, C.; Pott, H.-G.; Lendl, U. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗